Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells

Journal of Nutritional Biochemistry

Volumn 17, Issue 5, 2006, Pages 356-362

  Hwang, Hye Jin ^a   Park, Hyen Joo ^a   Chung, Hwa Jin ^a   Min, Hye Young ^a   Park, Eun Jung ^a   Hong, Ji Young ^a   Lee, Sang Kook ^a  

^a Ewha Womans University   (South Korea)

Author keywords

Caffeic acid phenethyl ester (CAPE); Extracellular matrix (ECM); Matrix metalloproteinase 2 (MMP 2); Matrix metalloproteinase 9 (MMP 9); Metastasis

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; GELATIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; ZINC;

ARTICLE; CANCER CELL; CANCER INVASION; CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; COLONY FORMATION; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; EXTRACELLULAR MATRIX; FIBROSARCOMA; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; METASTASIS INHIBITION; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

CAFFEIC ACIDS; CELL LINE, TUMOR; FIBROSARCOMA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; NEOPLASM METASTASIS; PHENYLETHYL ALCOHOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

APIS MELLIFERA;

EID: 33646085333     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2005.08.009     Document Type: Article

References (42)

1. Grunberger D., Banerjee R., Eisinger K., Oltz E.M., Efros L., Caldwell M., et al. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia 44 (1988) 230-232
2. Nagaoka T., Banskota A.H., Tezuka Y., Saiki I., and Kadota S. Selective antiproliferative activity of caffeic acid phenethyl ester analogues on highly liver-metastatic murine colon 26-L5 carcinoma cell line. Bioorg Med Chem 10 (2002) 3351-3359
3. Vieira O., Laranjinha J., Madeira V., and Almeida L. Cholesteryl ester hydroperoxide formation in myoglobin-catalyzed low density lipoprotein oxidation: concerted antioxidant activity of caffeic and p-coumaric acids with ascorbate. Biochem Pharmacol 55 (1998) 333-340
4. Koshihara Y., Neichi T., Murota S., Lao A., Fujimoto Y., and Tatsuno T. Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochim Biophys Acta 792 (1984) 92-97
5. Michaluart P., Masferrer J.L., Carothers A.M., Subbaramaiah K., Zweifel B.S., Koboldt C., et al. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res 59 (1999) 2347-2352
6. Chan W.S., Wen P.C., and Chiang H.C. Structure-activity relationship of caffeic acid analogues on xanthine oxidase inhibition. Anticancer Res 15 (1995) 703-707
7. Schefferlie J.G., and van Bladeren P.J. In vitro and in vivo reversible and irreversible inhibition of rat glutathione S-transferase isoenzymes by caffeic acid and its 2-S-glutathionyl conjugate. Food Chem Toxicol 31 (1993) 475-482
8. Tanaka T., Kojima T., Kawamori T., Wang A., Suzui M., Okamoto K., et al. Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis 14 (1993) 1321-1325
9. Frenkel K., Wei H., Bhimani R., Ye J., Zadunaisky J.A., Huang M.T., et al. Inhibition of tumor promoter-mediated processes in mouse skin and bovine lens by caffeic acid phenethyl ester. Cancer Res 53 (1993) 1255-1261
10. Fernandez M.A., Saenz M.T., and Garcia M.D. Anti-inflammatory activity in rats and mice of phenolic acids isolated from Scrophularia frutescens. J Pharm Pharmacol 50 (1998) 1183-1186
11. Wang D., Xiang D.B., He Y.J., Li Z.P., Wu X.H., Mou J.H., et al. Effect of caffeic acid phenethyl ester on proliferation and apoptosis of colorectal cancer cells in vitro. World J Gastroenterol 11 (2005) 4008-4012
12. Kashiwada Y., Nishizawa M., Yamagishi T., Tanaka T., Nonaka G., Cosentino L.M., et al. Anti-AIDS agents: 18. Sodium and potassium salts of caffeic acid tetramers from Arnebia euchroma as anti-HIV agents. J Nat Prod 58 (1995) 392-400
13. Fesen M.R., Kohn K.W., Leteurtre F., and Pommier Y. Inhibitors of human immunodeficiency virus integrase. Proc Natl Acad Sci U S A 90 (1993) 2399-2403
14. Liao H.F., Chen Y.Y., Liu J.J., Hsu M.L., Shieh H.J., Liao H.J., et al. Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J Agric Food Chem 51 (2003) 7907-7912
15. Chung T.W., Moon S.K., Chang Y.C., Ko J.H., Lee Y.C., Cho G., et al. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J 18 (2004) 1670-1681
16. Westermarck J., and Kähäri V.-M. Regulation of metalloproteinase expression in tumor invasion. FASEB J 13 (1999) 781-792
17. Itoh T., Tanioka M., Yoshida H., Yoshioka T., Nishimoto H., and Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58 (1998) 1048-1051
18. Watanabe H., Nakanishi I., Yamashita K., Hayakawa T., and Okada Y. Matrix metalloproteinase-9 (92 kD gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J Cell Sci 104 (1993) 991-999
19. Gomez D.E., Alonso D.F., Yoshiji H., and Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74 (1997) 111-122
20. Denhardt D.T., Feng B., Edwards D.R., Cocuzzi E.T., and Malyankar U.M. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther 59 (1993) 329-441
21. Butler G.S., Butler M.J., Atkinson S.J., Will H., Tamura T., van Westrum S.S., et al. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. J Biol Chem 273 (1998) 871-880
22. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., and Goldberg G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270 (1995) 5331-5338
23. Zucker S., Drews M., Conner C., Foda H.D., DeClerck Y.A., Langley K.E., et al. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 273 (1998) 1216-1222
24. Coussens L.M., Tinkle C.L., Hanahan D., and Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103 (2000) 481-490
25. Ballester A., Velasco A., Tobena R., and Alemany S. Cot kinase activates tumor necrosis factor-alpha gene expression in a cyclosporin A-resistant manner. J Biol Chem 273 (1998) 14099-14106
26. Herron G.S., Banda M.J., Clark E.J., Gavrilovic J., and Werb Z. Secretion of metalloproteinases by stimulated capillary endothelial cells: II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem 261 (1986) 2814-2818
27. Giancotti F.G., and Ruoslahti E. Integrin signaling. Science 285 (1999) 1028-1032
28. Stetler-Stevenson W.G. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9 (1990) 289-303
29. Zeng Z.S., Cohen A.M., and Guillem J.G. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis 20 (1999) 749-755
30. Oba K., Konno H., Tanaka T., Baba M., Kamiya K., Ohta M., et al. Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166. Cancer Lett 175 (2002) 45-51
31. Liotta L.A., Steeg P., and Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64 (1991) 327-336
32. Birkedal-Hansen H., Moore W.G., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4 (1993) 197-250
33. Itoh T., Tanioka M., Matsuda H., Nishimoto H., Yoshioka T., Suzuki R., et al. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 17 (1999) 177-181
34. Stetler-Stevenson W.G., Brown P.D., Onisto M., Levy A.T., and Liotta L.A. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 265 (1990) 13933-13938
35. Shao Z.M., Wu J., Shen Z.Z., and Barsky S.H. Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 58 (1998) 4851-4857
36. Yoon S.O., Kim M.M., and Chung A.S. Inhibitory effect of selenite on invasion of HT1080 tumor cells. J Biol Chem 276 (2001) 20085-20092
37. Cha H.J., Bae S.K., Lee H.Y., Lee O.H., Sato H., Seiki M., et al. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res 56 (1996) 2281-2284
38. 3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 11 (2000) 221-229
39. Chu S.C., Chiou H.L., Chen P.N., Yang S.F., and Hsieh Y.S. Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Mol Carcinog 40 (2004) 143-149
40. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370 (1994) 61-65
41. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17 (2001) 463-516
42. Forget M.A., Desrosiers R.R., and Beliveau R. Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis. Can J Physiol Pharmacol 77 (1999) 465-480